100 related articles for article (PubMed ID: 4020167)
1. In vitro phase II trial of recombinant interferon alpha-2 in gastrointestinal cancer.
Scheithauer W; Temsch EM; Schieder K; Funovics H; Schiessel R; Grabner G
Int J Cell Cloning; 1985 Jul; 3(4):188-98. PubMed ID: 4020167
[TBL] [Abstract][Full Text] [Related]
2. [In vitro evaluation of the chemosensitivity of malignant gastrointestinal tumors by stem cell assay].
Scheithauer W; Temsch EM; Schieder H; Funovics J; Schiessel R; Grabner G
Acta Med Austriaca; 1984; 11(3-4):119-24. PubMed ID: 6475472
[TBL] [Abstract][Full Text] [Related]
3. [The current status of chemo- or immunotherapy of gastrointestinal tumors].
Schmidt M; Gropp C; Martini GA
Internist (Berl); 1978 Dec; 19(12):692-9. PubMed ID: 217849
[No Abstract] [Full Text] [Related]
4. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
Furue H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effect of interferons with chemotherapeutic agents].
Kimoto Y
Gan To Kagaku Ryoho; 1986 Feb; 13(2):293-301. PubMed ID: 3080964
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of the combined effects of mitomycin C with alpha-interferon or gamma-interferon by the clonogenic assay technique].
Hirabayshi N; Nishiyama M; Yamaguchi M; Yoshinaka K; Nosoh Y; Toge T; Niimoto M; Hattori T; Ohkita T
Gan To Kagaku Ryoho; 1985 May; 12(5):1056-62. PubMed ID: 3922307
[TBL] [Abstract][Full Text] [Related]
7. [Combined effect of interferons alpha, beta and gamma on tumor growth in vitro].
Kimoto Y
Gan To Kagaku Ryoho; 1986 Feb; 13(2):302-7. PubMed ID: 3080965
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
[TBL] [Abstract][Full Text] [Related]
9. [Current status of the human tumor clonogenic assay for gastrointestinal cancer].
Tanigawa N
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1588-92. PubMed ID: 4026328
[TBL] [Abstract][Full Text] [Related]
10. Effects of cloned human leukocyte interferons in the human tumor stem cell assay.
Salmon SE; Durie BG; Young L; Liu RM; Trown PW; Stebbing N
J Clin Oncol; 1983 Mar; 1(3):217-25. PubMed ID: 6686847
[TBL] [Abstract][Full Text] [Related]
11. [In vitro phase II-III study by clonogenic assay: the combined effects of mitomycin C with alpha-interferon].
Hirabayashi N; Nosoh Y; Toge T; Yoshinaka K; Yamaguchi M; Nishiyama M; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):531-5. PubMed ID: 3082290
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
13. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
14. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial.
Kuchler T; Henne-Bruns D; Rappat S; Graul J; Holst K; Williams JI; Wood-Dauphinee S
Hepatogastroenterology; 1999; 46(25):322-35. PubMed ID: 10228816
[TBL] [Abstract][Full Text] [Related]
15. Activity of oxaliplatin against human tumor colony-forming units.
Raymond E; Lawrence R; Izbicka E; Faivre S; Von Hoff DD
Clin Cancer Res; 1998 Apr; 4(4):1021-9. PubMed ID: 9563898
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases.
Kornmann M; Fakler H; Butzer U; Beger HG; Link KH
Anticancer Res; 2000; 20(5A):3259-64. PubMed ID: 11062751
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of metastatic carcinoma cell growth in livers by poly(I):poly(C)/cationic liposome complex (LIC).
Hirabayashi K; Yano J; Takesue H; Fujiwara N; Irimura T
Oncol Res; 1999; 11(11-12):497-504. PubMed ID: 10905561
[TBL] [Abstract][Full Text] [Related]
18. Augmented immunity in cancer patients treated with alpha-interferon.
Neefe JR; Sullivan JE; Ayoob M; Phillips E; Smith FP
Cancer Res; 1985 Feb; 45(2):874-8. PubMed ID: 3967248
[TBL] [Abstract][Full Text] [Related]
19. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
[TBL] [Abstract][Full Text] [Related]
20. Growth and differentiation of human gastrointestinal adenocarcinoma stem cells in soft agarose.
Laboisse CL; Augeron C; Potet F
Cancer Res; 1981 Jan; 41(1):310-5. PubMed ID: 7448770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
